2D

two-Android次元

AF

心房細動

AMI

急性心筋梗塞

AR

大動脈弁閉鎖不全症

AV

房室

BSE

British Society of Echocardiography

CAF

chronic atrial fibrillation

CARAF

Canadian Registry of Atrial Fibrillation

CEAF

cost->Atrial Fibrillation

Canadian Registry of Atrial FibrillationCHA2DS2-VASc

congestive heart failure, 高血圧、年齢75歳以上（2倍）、糖尿病、脳卒中（2倍）、血管疾患、年齢65～74歳、性区分（女性）

CHADS2

心不全、高血圧、年齢、糖尿病。 脳卒中倍増

CHF

congestive heart failure

CI

confidence interval

CrI

credible interval

CT

computerised tomography

DES

discrete event simulation

DM

diabetes mellitus

ECG

electrocardiography

ESC

European Society of Cardiology

EVPI

完全情報の期待値

EVPPI

部分完全情報の期待値

FN

false-

FPPI

完全情報の期待値

EVPI

部分完全情報の期待値

EVC

European Society of Cardiology

EVPI

完全情報の期待値陰性

FP

偽陽性

GI

胃腸

GOS

グラスゴーアウトカムスケール

GP

一般開業医

HR

危険率

HRG

医療資源グループ

ICER

増分コスト-

GOS GSR(胃腸管)GSR>GOS

グラスゴー・アウトカムスケール

GOS

胃腸管(胃腸管)

GOS

胃腸管(胃腸管)有効比率

ICH

頭蓋内出血

ICM

虚血性心筋症

INR

国際標準化比率

LA

左房

LAA

左房付属器

LAD

左房径

LV

左心室

M-。モード

motionMAICER

maximum acceptable incremental cost effectiveness ratio

MI

myocardial infarction

MR

mitral regurgitation

MRI

magnetic resonance imaging

mRS

modifed Rankin Scale

MVP

mitral valve prolapse

NCC-> MVP

maximum acceleration

MAP MAP MAP MAP MAP MAP MAP MAP MAP MIP MAP MIP National Collaborating Centre for Chronic Conditions NICE

National Institute for Health and Care Excellence

NSF

National Service Framework

OAC

oral anticoagulant

OR

odds ratio

PE

pulmonary embolism

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta->

Preferred Reporting Items for Chronic Conditions＜5054> NICEF

National Health and Care Excellence

NSF

National Service Framework＜5054> OAC

oral anticoagulant＜5054> OR

odds ratio＜5054PSA

probabilistic sensitivity analysis

QALY

quality-adjusted life-year

QUADAS

quality assessment of studies of diagnostic accuracy included in systematic reviews

RA

right atrial

RAA

right atrial appendage

RCT

randomised controlled trial

RE- RMT

randomised control trial

RE- RCT Randomized Evaluation of Long-Term Anticoagulation Therapy RR

relative risk

RV

right ventricular

SPAF

Stroke Prevention in Atrial Fibrillation

STROBE

Strengthening Reporting of Observational Studies in Epidemiology

TIA

transient ischaemic attack

TN

true->Thrue-After Effects

TN

Trouble-After Effects

Transient ischaemic attack TIA

Transient Ischaemic attack

True->True-After Effects TOE

transoesophageal echocardiography

TP

true-positive

TTE

transthoracic echocardiography

WoS

Web of Science